Regulatory guidelines are essential for the clinical translation of hydrogels and bioinks. Such regulations have been defined to ensure that these innovative materials fulfill the required standards. Any product intended for clinical application must be designed based on manufacturing and regulatory requirements from the start. The FDA (Food and Drug Administration) and MDR (Medical Device Regulation) are two major regulatory systems for clinical approval in the United States and the European Union, respectively. While both systems aim to ensure the safety, efficacy, and quality of products, MDR imposes stricter requirements. Most of the medical devices drop out due to issues of safety, lack of efficacy, or not meeting the standards defined by the regulatory authorities. According to statistics, the average timeframe for bringing a new device to market is about 7–10 years. This is longer for a new drug. This highlights the difference in approval pathways for medical devices versus drugs. Guidelines written by authorities for new drugs or devices are to ensure they are safe and effective and exhibit high quality before going to the clinic.